Efficacy and Safety Study of a Recombinant and Protein-Free Factor VIII (rAHF-PFM) in Pediatric Patients in Canada With Hemophilia A - A Continuation of Baxter Study 060101
Clinical trial NCT00189982 · COMPLETED
Trial details
- NCT number
- NCT00189982
- Sponsor
- Baxalta now part of Shire
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2004-12-17
- Primary completion
- 2006-11-10
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.